• There are no items in your cart

ASTM E 2363 : 2023

Current

Current

The latest, up-to-date edition.

Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

23-02-2023

€61.92
Excluding VAT

Committee
E 55
DocumentType
Reference Material
Pages
16
PublisherName
American Society for Testing and Materials
Status
Current
Supersedes

1.1This standard covers terminology used by the E55 Committee relating to pharmaceutical and biopharmaceutical industry for manufacture of pharmaceutical and biopharmaceutical products. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to pharmaceutical and biopharmaceutical manufacturing may be more clearly stated.

1.2This terminology is, therefore, intended to be selective of terms used generally in the manufacture of pharmaceutical and biopharmaceutical products and published in a number of documents such as those listed in the succeeding section. The listing is also intended to define terms that appear prominently within other related ASTM International standards and do not appear elsewhere.

1.3The definitions are substantially identical to those published by regulatory agencies such as the U.S. Food and Drug Administration, European Medicines Agency, Pharmaceutical and Medical Devices Agency (Japan), other and national competent authorities (human) as well as other authoritative bodies, such as ICH, ISO, and national standards organizations.

1.4This terminology supplements current documents on terminology that concentrate on the manufacture of pharmaceutical and biopharmaceutical products.

1.5An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with the manufacture of pharmaceutical and biopharmaceutical products.

1.6Units—The values stated in SI units are to be regarded as the standard. No other units of measurement are included in this standard.

1.7This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.8This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

ASTM E 2891 : 2020 Standard Guide for Multivariate Data Analysis in Pharmaceutical Development and Manufacturing Applications
ASTM E 3072 : 2022 : REV A Standard Terminology for Industrial Biotechnology and Synthetic Biology
ASTM E 2476 : 2022 Standard Guide for Risk Assessment and Risk Control as it Impacts the Design, Development, and Operation of PAT Processes for Pharmaceutical Manufacture
ASTM E 3051 : 2016 Standard Guide for Specification, Design, Verification, and Application of Single-Use Systems in Pharmaceutical and Biopharmaceutical Manufacturing
ASTM E 2882 : 2019 Standard Guide for Analysis of Clandestine Drug Laboratory Evidence
ASTM E 3326 : 2022 Standard Guide for Application of Continuous Manufacturing (BioCM) in the Biopharmaceutical Industry
ASTM E 1732 : 2022 Standard Terminology Relating to Forensic Science
ASTM E 2968 : 2023 Standard Guide for Application of Continuous Manufacturing (CM) in the Pharmaceutical Industry
ASTM E 2537 : 2016 Standard Guide for Application of Continuous Process Verification to Pharmaceutical and Biopharmaceutical Manufacturing
ASTM E 2629 : 2020 Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems
ASTM E 2500 : 2020 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
ASTM E 2810 : 2019 Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units
ASTM E 3077 : 2017 : EDT 2 Standard Guide for Raw Material eData Transfer from Material Suppliers to Pharmaceutical & Biopharmaceutical Manufacturers
ASTM E 2656 : 2016 Standard Practice for Real-time Release Testing of Pharmaceutical Water for the Total Organic Carbon Attribute

ASTM E 2500 : 2020 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
ASTM E 456 : 2013 : REV A : R2022 Standard Terminology Relating to Quality and Statistics
ASTM E 456 : 2013 : REV A : R2022 : EDT 1 Standard Terminology Relating to Quality and Statistics
ASTM E 1565 : 2000 : R2019 Standard Guide for Inventory Control and Handling of Biological Material Maintained at Low Temperatures
ASTM E 1564 : 2000 : R2019 Standard Guide for Design and Maintenance of Low-Temperature Storage Facilities for Maintaining Cryopreserved Biological Materials
ASTM E 1566 : 2000 : R2019 Standard Guide for Handling Hazardous Biological Materials in Liquid Nitrogen
ASTM E 2629 : 2020 Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.